课题基金 / 基金详情

Pathogenesis of chronic hepatitis C and hepatocellular carcinoma and predictive factors determined by data mining

Pathogenesis of chronic hepatitis C and hepatocellular carcinoma and predictive factors determined by data mining
慢性丙型肝炎和肝细胞癌的发病机制及数据挖掘确定的预测因素
批准号:
18590724
负责人:
ASAHINA Yasuhiro
金额:
$2.57万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

ASAHINA Yasuhiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
BACKGROUND: Mechanisms involving resistance to interferon (IFN) and ribavirin (RBV) have wit been fully elucidated, and prediction of treatment responses before initiation of therapy is difficult. RIG-I and the related MDA5 initiate the host antiviral response by detecting intracellular viral dsRNA. Cardif (ISP-I, MAVS, VISA) is an adaptor molecule that connects RIG-I sensing to downstream signaling. On the other hand, LGP2, a helicase belonging RIG-I family, and an E3 ubiquitin ligase have been shown to negatively regulate RIG-I sensing. Moreover, these molecules are ISGylated by ISG15, a ubiquitin-like protein However; the clinical significance of these innate immune systems in terms of treatment response is unclear.AIM: To elucidate the mechanisms underlying resistance to PEG-IFN plus RBV, and to determine whether analysis of the innate immune system is useful in predicting treatment responses.METHODS: We studied 74 chronic hepatitis C virus (HCV) patients with genotype lb treated w … More ith PEG-IFN alfa-2b plus RBV for 48 weeks and 5 patients with non-viral liver disease. Pretreatment hepatic mRNA expressions of RIG-I, Cardif MDA5, LGP2, ISG15, USP18 (a specific remover of ISMS from ISGylated protein), and serum HCV dynamics during therapy were measured by real-time PCR. G3PDH and HMB were used as internal controls.RESULTS: Thirty-four patients were sustained virological responders (SVR), 24 were transient responders (TR), and 20 were non-virological responders (NVR). The hepatic levels of all transcripts except Cardif were 2. to 8-fold higher in HCV patients than non-HCV patients. RIG-I, MDA5, and LGP2 expression was significantly up-regulated in NVR compared with TR or SVR. Cardif expression negatively correlated with RIG-I expression and was significantly suppressed in NVR. The difference between NVR and SVR or TR in the RIG-I/Cardif expression ratio was pronounced (NVR/PR/SVR = 1.2/0.6/0.5 copies/control). Like RIG-I and MDA5, ISG15 and USP18 expression was significantly up-regulated in NVR (ISG15, NVR/TR/SVR = 0.8/0.4/0.2 copies/control; USP18, NVRTR/SVR = 0.9/0.6/0.4 copies/control). The RIG-I/Cardif ratio and the expression of MDA5, ISG15, and USP18 significantly correlated with viral decline rates in the first and second phases of HCV dynamics. Multivariate and ROC analyses revealed that a higher ratio of RIG-I/Cardif and a higher expression of MDA5, ISG15, and USP18 predicted NW.CONCLUSION: Intracellular sensors and their regulators were variously up-regulated upon HCV infection especially in NVR Quantifying hepatic gene expression involving an innate immune system is of use in identifying patients who are at a higher risk for NVR. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PEG-IFN/RBV併用療法難知例の診断と治療の工夫
PEG-IFN/RBV联合治疗疑难病例的诊治思路
DOI: --
发表时间: 2006
期刊: 肝臓 47巻
影响因子: --
作者: [Namiki, Izumi, et. al., 朝比奈 靖浩, 朝比奈 靖浩, 朝比奈 靖浩, 朝比奈 靖浩, 朝比奈 靖浩, 朝比奈 靖浩, 朝比奈 靖浩, 朝比奈 靖浩, 朝比奈 靖浩, 朝比奈 靖浩]
通讯作者: 朝比奈 靖浩
DOI: --
发表时间: 2006
期刊: 肝臓 47巻
影响因子: --
作者: [Namiki, Izumi, et. al., 朝比奈 靖浩, 朝比奈 靖浩, 朝比奈 靖浩, 朝比奈 靖浩, 朝比奈 靖浩, 朝比奈 靖浩, 朝比奈 靖浩, 朝比奈 靖浩, 朝比奈 靖浩, 朝比奈 靖浩, 黒崎 雅之, 黒崎 雅之]
通讯作者: 黒崎 雅之
ウイルス肝炎の免疫学的機序と治療C型慢性肝炎に対するPEG-IFN/Ribavirin併用療法における難治要因の検討とその対策
病毒性肝炎的免疫机制及治疗 PEG-IFN/利巴韦林联合治疗慢性丙型肝炎的难治因素检查及对策
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [朝比奈靖浩, 他]
通讯作者:
C型肝炎の治療 PEG-IFN+リバビリン併用療法における難治要因の検討とその対策
丙型肝炎治疗:PEG-IFN+利巴韦林联合治疗难治因素的检查及对策
DOI: --
发表时间: 2007
期刊: 消化器科 45
影响因子: --
作者: [Namiki, Izumi, et. al., 朝比奈 靖浩]
通讯作者: 朝比奈 靖浩
27
    Human iPS-derived hepatocyte-like progenitor cells susceptible for hepatitis B virus infection
    • 批准号:
      25670366
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      ASAHINA Yasuhiro
    • 依托单位:
    Association of gene expression involving innate immunity and genetic variation in IL28B with antiviral response
    • 批准号:
      20590769
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      ASAHINA Yasuhiro
    • 依托单位:
    国内基金
    海外基金
    系统性探索不同N-glycan修饰对Interferonβ活性和稳定性影响
    • 批准号:
      21877063
    • 项目类别:
      面上项目
    • 资助金额:
      61.4万元
    • 批准年份:
      2018
    • 负责人:
      王鹏
    • 依托单位:
    控制肠道病毒71型感染的先天性免疫保护机制及其应用
    干扰素信号分子及其调控网络在抗HBV感染过程中的作用机制研究
    • 批准号:
      81171558
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2011
    • 负责人:
      宁琴
    • 依托单位:
    糖药物蛋白Interferonβ N-glycan的均一、人源化改造
    • 批准号:
      81102361
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      25.0万元
    • 批准年份:
      2011
    • 负责人:
      程剑松
    • 依托单位: